References
- Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. Journal of the American Medical A 1993;270:2475–2477.
- Armstrong RW, Steinbok P, Cochrane DD, Kube RN, Fife SE, Farrell K. Intrathecally administered Baclofen for treatment of children with spasticity of cerebral origin. Journal of Neurosurgery 1997;87:409–414.
- Gerszten PC, Albright AL, Barry MJ. Effect on ambulation of continuous intrathecal baclofen infusion. Journal of Neurology 1997;2:40–44.
- Gerszten PC, Albright AL, Johnstone GF. Intrathecal baclofen infusion and subsequent orthopaedic surgery in patients with spastic cerebral palsy. Journal of Neurosurgery 1998;88:1009–1013.
- Porter B. A review of intrathecal baclofen in the management of spasticity. British Journal of Nursing 1997;6:253–262.
- Krach L. Intrathecal baclofen significantly reduces spasticity and improves functioning, a paediatric perspective. Gillette Children’s Speciality Healthcare 1999;8.
- Creedon SD, Dijkers MP, Hinderer SR. Intrathecal baclofen for severe spasticity: a meta-analysis. International Journal of Rehabilitation and Health 1997;64:17–25.
- Keetley R, Morton R, Vloeberghs M. Management of spasticity in children with cerebral palsy, a national randomised controlled study on intrathecal baclofen. ACNR 2004;4:16–19.
- Morton RE, Murray-Leslie CF. The role of botulinum toxin in the management of cerebral palsy. Curent Paediatrics 2001;11:235–239.
- Novacheck TF, Stout JL, Teroo R. Reliability and validity of the Gilette functional assessment questionnaire as an outcome measure in children with walking disabilities. Journal of Pediatric Orthopaedics 2000;20:75–81.
- Sampson FC, Hayward A, Evans G. Touch S, Morton RE, Vloeberghs M, Playford D, Collett BJ, Critchley P. The effectiveness of intrathecal baclofen in the management of patients with severe spasticity. In: Payne N, editor. Guidance for Purchasers 00/01, 2000 (Trent Institute for Health Services Research. Universities of Leicester, Nottingham and Sheffield).
- Vloeberghs M, Cartmill M, Bassi S. The use of intrathecal baclofen in the management of spasticity in children with cerebral palsy. Child’s Nervous System 2000;18:540.
- Vloeberghs M, Cartmill M. The clinical outcome of the treatment of spasticity of cerebral origin with intrathecal baclofen varies with age. Early treatment is advised. Proceedings of the EANS winter meeting 2, Adults and Children: Impact of the age on Neurosurgical diseases 2002.
- Vloeberghs M, Fitzgerald J, Tsegaye M, Cartmill M. Aspects of the treatment of spasticity due to cerebral palsy in children with intrathecal baclofen. Childs Nervous System 2003;19:634.
- Vloeberghs M. Intrathecal baclofen in the management of spasticity in children. Advances in Child Neurology and Rehabilitation 2002;12:11–13.